Analytical Data
-
基因名
idnk
- Application
-
别名
IDNK;C9orf103;Probable gluconokinase
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P39208
-
表达区间
1-187aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSMAGESFI LMGVSGSGKT LIGSKVAALL SAKFIDGDDL HPAKNIDKMS QGIPLSDEDR LPWLERLNDA SYSLYKKNET GFIVCSSLKK QYRDILRKGS PHVHFLWLDG DYETILARMQ RRAGHFMPVA LLKSQFEALE RPQADEQDIV RIDINHDIAN VTEQCRQAVL AIRQNRICAK EGSASDQRCE
-
分子量
23 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IDNK (Inhibitor of DNA Damage Kinase) is an emerging protein that has garnered significant interest in the field of molecular biology and cancer research due to its potential role in cellular response to DNA damage and repair mechanisms. Research indicates that IDNK may play a crucial role in regulating key pathways associated with DNA damage response (DDR), which is essential for maintaining genomic stability. The dysregulation of this protein could contribute to tumorigenesis and cancer progression, making it a potential target for therapeutic intervention. Studies have begun to explore the structural characteristics of IDNK, its interaction with other proteins involved in the DDR network, and its implication in various cancer types. Furthermore, understanding the molecular mechanisms underlying IDNK's function may provide insights into developing novel strategies for cancer treatment, particularly in tumors exhibiting resistance to conventional therapies. As researchers delve deeper into the biological functions and regulatory mechanisms of IDNK, the hope is that these findings will contribute to the advancement of precision medicine approaches in oncology.
